BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 30242085)

  • 1.
    Balatti V; Tomasello L; Rassenti LZ; Veneziano D; Nigita G; Wang HY; Thorson JA; Kipps TJ; Pekarsky Y; Croce CM
    Blood; 2018 Nov; 132(20):2179-2182. PubMed ID: 30242085
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miR-34a and miR-29b as indicators for prognosis of treatment-free survival of chronic lymphocytic leukemia patients in Chinese Uygur and Han populations.
    Li Y; Mao M; Liu H; Wang X; Kou Z; Nie Y; Wang Y; Wang Z; Huang Q; Lang T; Gu Z; An L; Zhang X; Fu L
    Mol Cell Probes; 2019 Oct; 47():101436. PubMed ID: 31425738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. microRNA-34a expression correlates with MDM2 SNP309 polymorphism and treatment-free survival in chronic lymphocytic leukemia.
    Asslaber D; Piñón JD; Seyfried I; Desch P; Stöcher M; Tinhofer I; Egle A; Merkel O; Greil R
    Blood; 2010 May; 115(21):4191-7. PubMed ID: 20089965
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-155-5p Overexpression in Peripheral Blood Mononuclear Cells of Chronic Lymphocytic Leukemia Patients Is a Novel, Independent Molecular Biomarker of Poor Prognosis.
    Papageorgiou SG; Kontos CK; Diamantopoulos MA; Bouchla A; Glezou E; Bazani E; Pappa V; Scorilas A
    Dis Markers; 2017; 2017():2046545. PubMed ID: 29463948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tcl1 expression in chronic lymphocytic leukemia is regulated by miR-29 and miR-181.
    Pekarsky Y; Santanam U; Cimmino A; Palamarchuk A; Efanov A; Maximov V; Volinia S; Alder H; Liu CG; Rassenti L; Calin GA; Hagan JP; Kipps T; Croce CM
    Cancer Res; 2006 Dec; 66(24):11590-3. PubMed ID: 17178851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The expression and prognostic significance of microRNA-34a in Uygur and Han patients with chronic lymphocytic leukemia in Xinjiang Uygur Autonomous Region in China].
    Liu H; Wang XM; Mao M; Fu L; Huang Q; Wang YL; Wang YC; Wang ZS; Li Y
    Zhonghua Nei Ke Za Zhi; 2018 Dec; 57(12):922-925. PubMed ID: 30486562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NDRG2 mRNA levels and miR-28-5p and miR-650 activity in chronic lymphocytic leukemia.
    Yang YQ; Tian T; Zhu HY; Liang JH; Wu W; Wu JZ; Xia Y; Wang L; Fan L; Li JY; Xu W
    BMC Cancer; 2018 Oct; 18(1):1009. PubMed ID: 30348117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exosome-carried microRNA-based signature as a cellular trigger for the evolution of chronic lymphocytic leukemia into Richter syndrome.
    Jurj A; Pop L; Petrushev B; Pasca S; Dima D; Frinc I; Deak D; Desmirean M; Trifa A; Fetica B; Gafencu G; Selicean S; Moisoiu V; Micu WT; Berce C; Sacu A; Moldovan A; Colita A; Bumbea H; Tanase A; Dascalescu A; Zdrenghea M; Stiufiuc R; Leopold N; Tetean R; Burzo E; Tomuleasa C; Berindan-Neagoe I
    Crit Rev Clin Lab Sci; 2018 Nov; 55(7):501-515. PubMed ID: 30238808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA expression in chronic lymphocytic leukemia developing autoimmune hemolytic anemia.
    Ferrer G; Navarro A; Hodgson K; Aymerich M; Pereira A; Baumann T; Monzo M; Moreno C; Montserrat E
    Leuk Lymphoma; 2013 Sep; 54(9):2016-22. PubMed ID: 23286334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR-181a/b significantly enhances drug sensitivity in chronic lymphocytic leukemia cells via targeting multiple anti-apoptosis genes.
    Zhu DX; Zhu W; Fang C; Fan L; Zou ZJ; Wang YH; Liu P; Hong M; Miao KR; Liu P; Xu W; Li JY
    Carcinogenesis; 2012 Jul; 33(7):1294-301. PubMed ID: 22610076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNAs in chronic lymphocytic leukemia pathogenesis and disease subtypes.
    Mraz M; Pospisilova S; Malinova K; Slapak I; Mayer J
    Leuk Lymphoma; 2009 Mar; 50(3):506-9. PubMed ID: 19347736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated miR-20b-5p expression in peripheral blood mononuclear cells: A novel, independent molecular biomarker of favorable prognosis in chronic lymphocytic leukemia.
    Papageorgiou SG; Kontos CK; Tsiakanikas P; Stavroulaki G; Bouchla A; Vasilatou D; Bazani E; Lazarakou A; Scorilas A; Pappa V
    Leuk Res; 2018 Jul; 70():1-7. PubMed ID: 29715621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aberrant expression profile of miR-32, miR-98 and miR-374 in chronic lymphocytic leukemia.
    Rahimi Z; Ghorbani Z; Motamed H; Jalilian N
    Leuk Res; 2021 Dec; 111():106691. PubMed ID: 34455196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-34a and miR-125a-5p inhibit proliferation and metastasis but induce apoptosis in hepatocellular carcinoma cells via repressing the MACC1-mediated PI3K/AKT/mTOR pathway.
    Zhang YM; Wu QM; Chang LY; Liu JC
    Neoplasma; 2020 Sep; 67(5):1042-1053. PubMed ID: 32484698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA miR-34a downregulates FOXP1 during DNA damage response to limit BCR signalling in chronic lymphocytic leukaemia B cells.
    Cerna K; Oppelt J; Chochola V; Musilova K; Seda V; Pavlasova G; Radova L; Arigoni M; Calogero RA; Benes V; Trbusek M; Brychtova Y; Doubek M; Mayer J; Pospisilova S; Mraz M
    Leukemia; 2019 Feb; 33(2):403-414. PubMed ID: 30111844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic lymphocytic leukemia modeled in mouse by targeted miR-29 expression.
    Santanam U; Zanesi N; Efanov A; Costinean S; Palamarchuk A; Hagan JP; Volinia S; Alder H; Rassenti L; Kipps T; Croce CM; Pekarsky Y
    Proc Natl Acad Sci U S A; 2010 Jul; 107(27):12210-5. PubMed ID: 20566844
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic Value of Plasma miR-145 and miR-185 as Targeting of the APRIL Oncogene in the B-cell Chronic Lymphocytic Leukemia.
    Bagheri M; Khansarinejad B; Mosayebi G; Moradabadi A; Mondanizadeh M
    Asian Pac J Cancer Prev; 2021 Jan; 22(1):111-117. PubMed ID: 33507687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-4 Up-Regulates MiR-21 and the MiRNAs Hosted in the CLCN5 Gene in Chronic Lymphocytic Leukemia.
    Ruiz-Lafuente N; Alcaraz-García MJ; Sebastián-Ruiz S; García-Serna AM; Gómez-Espuch J; Moraleda JM; Minguela A; García-Alonso AM; Parrado A
    PLoS One; 2015; 10(4):e0124936. PubMed ID: 25909590
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-34a, miR-29c and miR-17-5p are downregulated in CLL patients with TP53 abnormalities.
    Mraz M; Malinova K; Kotaskova J; Pavlova S; Tichy B; Malcikova J; Stano Kozubik K; Smardova J; Brychtova Y; Doubek M; Trbusek M; Mayer J; Pospisilova S
    Leukemia; 2009 Jun; 23(6):1159-63. PubMed ID: 19158830
    [No Abstract]   [Full Text] [Related]  

  • 20. The involvement of microRNA in the pathogenesis of Richter syndrome.
    Van Roosbroeck K; Bayraktar R; Calin S; Bloehdorn J; Dragomir MP; Okubo K; Bertilaccio MTS; Zupo S; You MJ; Gaidano G; Rossi D; Chen SS; Chiorazzi N; Thompson PA; Ferrajoli A; Bertoni F; Stilgenbauer S; Keating MJ; Calin GA
    Haematologica; 2019 May; 104(5):1004-1015. PubMed ID: 30409799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.